cdmo.directory
← Compare landing

ACS Dobfar vs Capitol Biologics

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/acs-dobfar/capitolbiologics

CategoryACS DobfarCapitol Biologics
Listed sitecdmocdmo
SummaryItalian CDMO with 50 years of experience offering custom development and manufacturing of active pharmaceutical ingredients, finished dosage forms, and biotech solutions including monoclonal antibodies, with FDA and AIFA approvals.Capitol Biologics is a full-service CDMO supporting R&D and early-phase clinical trial manufacturing for emerging biotech firms. It focuses on biologics, proteins, and monoclonal antibodies from cell line development through GMP manufacturing.
Services
  • API Synthesis & Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Extractables & Leachables Studies
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Formulation Development
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Infectious Disease
Data not yet provided.
Locations
  • Headquarters, Tribiano, Milan, Italy
  • Frederick, Frederick, MD, US
Certifications
  • FDA · Identifier: FDA
  • AIFA · Identifier: AIFA
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.